Land Matthew R, Patel Parth A, Bui Tommy, Jiao Cheng, Ali Arsalan, Ibnamasud Shadman, Patel Prem N, Sheth Veeral
Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Burnett School of Medicine, Texas Christian University, Fort Worth, TX 76129, USA.
J Clin Med. 2023 May 18;12(10):3537. doi: 10.3390/jcm12103537.
With the increasing prevalence of diabetic retinopathy (DR), screening is of the utmost importance to prevent vision loss for patients and reduce financial costs for the healthcare system. Unfortunately, it appears that the capacity of optometrists and ophthalmologists to adequately perform in-person screenings of DR will be insufficient within the coming years. Telemedicine offers the opportunity to expand access to screening while reducing the economic and temporal burden associated with current in-person protocols. The present literature review summarizes the latest developments in telemedicine for DR screening, considerations for stakeholders, barriers to implementation, and future directions in this area. As the role of telemedicine in DR screening continues to expand, further work will be necessary to continually optimize practices and improve long-term patient outcomes.
随着糖尿病视网膜病变（DR）的患病率不断上升，筛查对于防止患者视力丧失以及降低医疗系统的财务成本至关重要。不幸的是，未来几年验光师和眼科医生充分进行DR面对面筛查的能力似乎将不足。远程医疗提供了扩大筛查机会的同时，减少与当前面对面诊疗方案相关的经济和时间负担。本文献综述总结了DR筛查远程医疗的最新进展、利益相关者的考虑因素、实施障碍以及该领域的未来方向。随着远程医疗在DR筛查中的作用不断扩大，有必要进一步开展工作，以持续优化诊疗方法并改善患者的长期预后。
